Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 29 locations and has been updated from Revision v2.9.7 to v2.10.0.
    Difference
    0.3%
    Check dated 2024-07-23T14:58:09.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:03:59.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-07-02T14:22:28.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has changed from v2.9.3 to v2.9.5, indicating an update or modification to the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-27T10:19:53.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T09:26:12.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Show more Revision: v2.9.0' has recently changed to 'Show less Show less'. This change represents an update in the content displayed on the webpage related to a clinical trial study involving trastuzumab deruxtecan and nivolumab for HER2-expressing advanced breast and urothelial cancer.
    Difference
    67%
    Check dated 2024-06-25T08:33:58.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.